Abeona Therapeutics (ABEO) Current Assets (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Current Assets of $183.0 million for Q1 2026, up 107.65% year-over-year from $88.1 million in Q1 2025, and down 10.7% quarter-over-quarter from $204.9 million in Q4 2025.
Abeona Therapeutics (ABEO) Current Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $183.0 million for Q1 2026.
- In Q1 2026, Current Assets rose 107.65% year-over-year to $183.0 million; the TTM figure through Mar 2026 stood at $183.0 million (up 107.65% YoY), while the FY2025 annual figure was $204.9 million, up 103.17% from the prior year.
- Current Assets for Q1 2026 stood at $183.0 million, down from $204.9 million in the prior quarter.
- The five-year high for Current Assets was $232.3 million in Q2 2025, with the low at $25.5 million in Q3 2022.
- The 5-year median for Current Assets is $66.7 million (2024), against an average of $98.7 million.
- The sharpest annual moves came in 2022 and 2024: Current Assets plunged 62.45% in 2022, then soared 185.9% in 2024.
- Abeona Therapeutics' Current Assets stood at $53.1 million in 2022, then rose by 4.97% to $55.7 million in 2023, then soared by 80.94% to $100.9 million in 2024, then jumped by 103.17% to $204.9 million in 2025, then declined by 10.7% to $183.0 million in 2026.
- Business Quant data shows ABEO's Current Assets at $183.0 million in Q1 2026, $204.9 million in Q4 2025, and $216.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 164.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 164.58 Mn |
| Mar 31, 2026 | 182.99 Mn |
| Dec 31, 2025 | 204.91 Mn |
| Sep 30, 2025 | 216.13 Mn |
| Jun 30, 2025 | 232.26 Mn |
| Mar 31, 2025 | 88.12 Mn |
| Dec 31, 2024 | 100.85 Mn |
| Sep 30, 2024 | 112.66 Mn |
| Jun 30, 2024 | 125.90 Mn |
| Mar 31, 2024 | 66.73 Mn |
| Dec 31, 2023 | 55.74 Mn |
| Sep 30, 2023 | 57.26 Mn |
| Jun 30, 2023 | 44.04 Mn |
| Mar 31, 2023 | 42.84 Mn |
| Dec 31, 2022 | 53.10 Mn |
| Sep 30, 2022 | 25.50 Mn |
| Jun 30, 2022 | 30.30 Mn |
| Mar 31, 2022 | 39.20 Mn |
| Dec 31, 2021 | 56.29 Mn |
| Sep 30, 2021 | 67.91 Mn |